药石科技
(300725)
| 流通市值：61.19亿 | | | 总市值：72.58亿 |
| 流通股本：1.68亿 | | | 总股本：2.00亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,127,892,555.29 | 744,866,670.76 | 377,460,431.51 | 1,725,203,986.49 |
| 营业收入 | 1,127,892,555.29 | 744,866,670.76 | 377,460,431.51 | 1,725,203,986.49 |
| 二、营业总成本 | 1,011,642,933.42 | 649,725,951.01 | 325,204,409.51 | 1,487,211,816.48 |
| 营业成本 | 679,864,500.58 | 440,405,050.85 | 216,310,157.43 | 991,669,209.12 |
| 税金及附加 | 17,540,681.08 | 10,898,051.85 | 5,103,201.63 | 18,631,576.34 |
| 销售费用 | 42,985,096.24 | 29,051,056.02 | 14,116,098 | 53,206,954 |
| 管理费用 | 141,017,046.95 | 94,301,313.87 | 47,045,256.92 | 200,229,764.67 |
| 研发费用 | 88,967,345.69 | 62,912,695.9 | 34,513,051.4 | 169,173,650.38 |
| 财务费用 | 41,268,262.88 | 12,157,782.52 | 8,116,644.13 | 54,300,661.97 |
| 其中:利息费用 | 46,623,371.19 | 30,449,852.19 | 15,409,320.04 | 66,095,508.06 |
| 其中:利息收入 | 8,174,798.96 | 6,221,903.31 | 4,042,244.04 | 13,438,804.03 |
| 加:公允价值变动收益 | 11,582,692.21 | 8,641,197.54 | 8,165,644.23 | -21,326,089.05 |
| 加:投资收益 | 28,565,584.66 | 20,031,118.36 | -2,072,743.28 | 11,353,439.98 |
| 资产处置收益 | - | - | - | 416,669.74 |
| 资产减值损失(新) | -28,151,110.54 | -25,518,399.75 | -7,748,338.22 | -37,720,296.35 |
| 信用减值损失(新) | 2,100,449.72 | 3,805,076.34 | 1,065,016.77 | -9,948,425.48 |
| 其他收益 | 7,184,657.22 | 1,775,022.17 | 1,172,355.3 | 3,832,524.22 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 137,531,895.14 | 103,874,734.41 | 52,837,956.8 | 184,599,993.07 |
| 加:营业外收入 | 12,430,579.45 | 6,990,131.65 | 2,772,139.04 | 41,060,256.37 |
| 减:营业外支出 | 1,963,547.52 | 135,130.45 | 5,771.94 | 4,285,206.4 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 147,998,927.07 | 110,729,735.61 | 55,604,323.9 | 221,375,043.04 |
| 减:所得税费用 | 16,208,108.47 | 12,038,236.25 | 6,118,964.7 | 24,014,109.74 |
| 六、净利润 | 131,790,818.6 | 98,691,499.36 | 49,485,359.2 | 197,360,933.3 |
| 持续经营净利润 | 131,790,818.6 | 98,691,499.36 | 49,485,359.2 | 197,360,933.3 |
| 归属于母公司股东的净利润 | 131,790,818.6 | 98,691,499.36 | 49,485,359.2 | 197,360,947.76 |
| 少数股东损益 | - | - | - | -14.46 |
| (一)基本每股收益 | 0.66 | 0.5 | 0.25 | 0.99 |
| (二)稀释每股收益 | 0.66 | 0.49 | 0.24 | 0.98 |
| 八、其他综合收益 | -1,064,749.3 | 602,109.27 | 141,525.36 | 1,512,231.52 |
| 归属于母公司股东的其他综合收益 | -1,064,749.3 | 602,109.27 | 141,525.36 | 1,512,231.52 |
| 九、综合收益总额 | 130,726,069.3 | 99,293,608.63 | 49,626,884.56 | 198,873,164.82 |
| 归属于母公司股东的综合收益总额 | 130,726,069.3 | 99,293,608.63 | 49,626,884.56 | 198,873,179.28 |
| 归属于少数股东的综合收益总额 | - | - | - | -14.46 |
| 公告日期 | 2024-10-30 | 2024-08-17 | 2024-04-24 | 2024-04-24 |
| 审计意见(境内) | | | | 标准无保留意见 |